NYXH Nyxoah SA
102
$8.50
$0.17
(2.04%)
| Watchers | 102 |
| 52-Wk Low | $4.00 |
| 52-Wk High | $20.00 |
| Market Cap | $243.63M |
| Volume | 154,851.00 |
| 52-Wk High | $20.00 |
| 52-Wk Low | $4.00 |
Information on the total number of voting rights and sharesGlobe Newswire • about 2 months ago
REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), March 29, 2024, 9:30 pm CET / 4:30 pm ET In accordance with article 15 of the Law...
Share to Feed
Nyxoah Advances Patient Access Strategy through Partnership with the American Association of Otolaryngology Head & Neck Surgery FoundationFirst medical device company to become a corporate champion...
HC Wainwright reaffirmed their buy rating on shares of Nyxoah (NASDAQ:NYXH Free Report) in a research note published on Wednesday, Benzinga reports. The firm currently has a $22.00 price...
Nyxoah (NASDAQ:NYXH Free Report) had its target price hoisted by Stifel Nicolaus from $20.00 to $27.00 in a report issued on Wednesday, Benzinga reports. Stifel Nicolaus currently has a buy...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Nyxoah says Genio pivotal study meets primary endpoints...
See the rest of the story here.
thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints Reports an Apnea-Hypopnea Index (AHI) responder rate of 63.5% on an intent to treat (ITT) basis (p=0.002)Reports an Oxygen...
HC Wainwright reissued their buy rating on shares of Nyxoah (NASDAQ:NYXH Free Report) in a research note published on Wednesday, Benzinga reports. HC Wainwright currently has a $18.00 target...